Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0605620050120020221
Journal of Korean Society of Biological Psychiatry
2005 Volume.12 No. 2 p.221 ~ p.226
OROS Methylphenidate Treatment of Secondary Adult ADHD after Traumatic Brain Injury
Lim Myung-Ho

Lee Woo-Chul
Abstract
The incidence of the Attention Deficit Hyperactivity Disorder secondary to the traumatic brain injury, such as traffic accidents, is increasing; the variety of the treatment modality is also increasing. This case was studied to see if OROS Methylphenidate(Concerta), which is one of the most commonly used medication in Attention Deficit Hyperactivity Disorder patients, not only improves the patient¡¯s attention, but also their impulsivity, hyperactivity and aggression. According to the case result, the medication showed an improvement of the impulsivity, aggression, and attention in the secondary Attention Deficit Hyperactivity Disorder patients after the traumatic brain injury.
KEYWORD
OROS Methylphenidate(Concerta), Traumatic Brain Injury(TBI), Adult attention deficity hyperactive disorder(ADHD)
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø